EC145
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for EC145, covering 2021-04-01 to 2021-09-30. Get the full timeline:
Most recent: Clinical Trial Update: Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED) [Phase 3]